Insights

Niche Market Focus RegMed Investors specializes in providing curated intelligence and insights on regenerative medicine and cell therapy companies, making it an ideal partner for vendors offering specialized tools, analytics, or content management solutions tailored to the biotech and healthcare investment sectors.

Emerging Sector Opportunities With a focus on cutting-edge therapies and companies demonstrating progress in regenerative medicine, there is potential for sales of advanced biotech research tools, data analytics platforms, and regulatory compliance solutions aimed at high-growth biotech firms.

Limited Revenue Size Operating with a revenue range of zero to one million dollars indicates a startup or small-scale operation, presenting opportunities for entry-level or scalable solutions in digital marketing, content management, or affordable cloud services to support growth.

Technological Ecosystem The company's tech stack, including Bootstrap, jQuery, and Google Analytics, suggests familiarity with web development and analytics, opening possibilities for selling advanced website optimization, user engagement tools, or customized digital marketing solutions.

Market Position & Growth As a company with a long-standing focus on regenerative medicine news and insight, there is a potential market for B2B solutions such as subscription-based content management systems, industry-specific data analytics, or professional networking platforms to expand their service offerings and enhance user engagement.

Similar companies to RegMed Investors

RegMed Investors Tech Stack

RegMed Investors uses 8 technology products and services including jsDelivr, Font Awesome, jQuery, and more. Explore RegMed Investors's tech stack below.

  • jsDelivr
    Content Delivery Network
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • CKEditor
    Rich Text Editors
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics
  • OpenSSL
    Web Server Extensions
  • Apache
    Web Servers

Media & News

RegMed Investors's Email Address Formats

RegMed Investors uses at least 1 format(s):
RegMed Investors Email FormatsExamplePercentage

Frequently Asked Questions

What is RegMed Investors's phone number?

Minus sign iconPlus sign icon
You can contact RegMed Investors's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is RegMed Investors's official website and social media links?

Minus sign iconPlus sign icon
RegMed Investors's official website is regmedinvestors.com and has social profiles on LinkedIn.

What is RegMed Investors's SIC code NAICS code?

Minus sign iconPlus sign icon
RegMed Investors's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 5239 - Other Financial Investment Activities.

How many employees does RegMed Investors have currently?

Minus sign iconPlus sign icon
As of December 2025, RegMed Investors has approximately 2 employees across 2 continents, including North AmericaAfrica. Key team members include Chairman And Publisher: H. M.Senior Vice President: B. P.Assets Control: H. S.. Explore RegMed Investors's employee directory with LeadIQ.

What industry does RegMed Investors belong to?

Minus sign iconPlus sign icon
RegMed Investors operates in the Investment Management industry.

What technology does RegMed Investors use?

Minus sign iconPlus sign icon
RegMed Investors's tech stack includes jsDelivrFont AwesomejQueryCKEditorBootstrapGoogle AnalyticsOpenSSLApache.

When was RegMed Investors founded?

Minus sign iconPlus sign icon
RegMed Investors was founded in 2001.

RegMed Investors

Investment ManagementMassachusetts, United States2-10 Employees

RegMed Investors <RMi> is the news portal focused on providing value-added intelligence, insight and pricing synthesis of stem and cell therapy companies demonstrating real progress toward their vision and meeting quarterly expectation. 

Now in our twelve year, we aggregate, curate and create bottom-line content weeding of regenerative medicine and cell therapy news to provide a customized, vetted selection of relevant and high-impact synthesis.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
5239 - Other Financial Investment Activities
Founded
2001
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    RegMed Investors's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    RegMed Investors's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.